REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 88 filers reported holding REVANCE THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $206,327 | -41.0% | 11,177 | -48.3% | 0.01% | -84.4% |
| Q3 2016 | $350,000 | +14.4% | 21,611 | -4.0% | 0.03% | -13.5% |
| Q2 2016 | $306,000 | +8.1% | 22,515 | +39.0% | 0.04% | -2.6% |
| Q1 2016 | $283,000 | -96.4% | 16,195 | -93.0% | 0.04% | -95.0% |
| Q4 2015 | $7,864,000 | +17.4% | 230,211 | +2.3% | 0.76% | +30.4% |
| Q3 2015 | $6,696,000 | -16.2% | 225,000 | -10.0% | 0.58% | +3.0% |
| Q2 2015 | $7,995,000 | +38.4% | 250,000 | -10.3% | 0.57% | +23.2% |
| Q1 2015 | $5,775,000 | +36.0% | 278,568 | +11.2% | 0.46% | +57.9% |
| Q4 2014 | $4,245,000 | +9.9% | 250,605 | +25.4% | 0.29% | +9.4% |
| Q3 2014 | $3,864,000 | -24.2% | 199,895 | +33.3% | 0.27% | -0.4% |
| Q2 2014 | $5,100,000 | +61.9% | 150,000 | +50.0% | 0.27% | +119.7% |
| Q1 2014 | $3,150,000 | – | 100,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |